BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38340953)

  • 1. Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applications.
    Jangra N; Kawatra A; Datten B; Gupta S; Gulati P
    Drug Discov Today; 2024 Apr; 29(4):103915. PubMed ID: 38340953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Bhatia R; Sharma A; Narang RK; Rawal RK
    Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-targeted nanocarriers for therapeutic delivery to cancer.
    Yu B; Tai HC; Xue W; Lee LJ; Lee RJ
    Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concepts on Smart Nano-Based Drug Delivery System.
    Rai S; Singh N; Bhattacharya S
    Recent Pat Nanotechnol; 2022; 16(1):67-89. PubMed ID: 33494685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges.
    Di Filippo LD; de Paula MC; Duarte JL; de Paula GA; Frigieri I; Chorilli M
    Expert Opin Drug Deliv; 2023 Jun; 20(6):831-849. PubMed ID: 37259517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances.
    Karimi M; Sahandi Zangabad P; Ghasemi A; Amiri M; Bahrami M; Malekzad H; Ghahramanzadeh Asl H; Mahdieh Z; Bozorgomid M; Ghasemi A; Rahmani Taji Boyuk MR; Hamblin MR
    ACS Appl Mater Interfaces; 2016 Aug; 8(33):21107-33. PubMed ID: 27349465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
    Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
    J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.